CDT Equity Inc. (NasdaqCM: CDT)
Health Care · Life Sciences Tools & Services · US
$0.72
-27.47% today · -100.0% 1Y
CDT Equity Inc. (NasdaqCM: CDT) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $807.40K and employs 4 people.
Over the last twelve months the share price has lost 100.0%, trading between 0.70 and 28.39K.
Tweenvest scores CDT Equity Inc. across four factors: quality 18/100, value 33/100. Its strongest factor is value.
CDT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $807.40K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 1.56
- 52-week high
- $28,390.00
- 52-week low
- $0.70
- Avg volume (3M)
- —
- Shares outstanding
- 1.12M
- Employees
- 4
- Next earnings
- —
About CDT Equity Inc.
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company’s pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto’s thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
- ISIN
- US20678X6013
- Founded
- 2019
- Listed since
- Mar 28, 2022
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cannabis Bioscience International Holdings, Inc.OTCPK: CBIH | $1.95M | $0.00 | -20.00% |
| Vanta Bioscience LimitedBSE: 540729 | $1.51M | Rs20.42 | -4.98% |
| Level Bio AB (publ)NGM: LEVBIO | $1.48M | Skr0.22 | -11.48% |
| Magle Chemoswed Holding AB (publ)OM: MAGLE | $1.22M | Skr0.40 | -16.94% |
| Attana AB (publ)NGM: ATANA | $774.24K | Skr0.00 | +50.00% |
| BNB Plus Corp.OTCPK: BNBX | $743.67K | $0.12 | -14.32% |
| Inhalation Sciences Sweden AB (publ)XSAT: ISAB | $415.43K | Skr0.08 | +4.69% |
| MetaStat, Inc.OTCPK: MTST | $319.73K | $— | — |
Figures last refreshed Oct 11, 2026.